J Lustgarten, AL Dominguez, M Thoman. (2004) "Aged mice develop protective antitumor immune responses with appropriate costimulation." J Immunol 173. 4510-5 PMID: 15383582 | Abstract and Keywords

AB Pillai, TI George, S Dutt, P Teo, S Strober. (2007) "Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation." J Immunol 178. 6242-51 PMID: 17475852 | Abstract and Keywords

Y Chung, H Qin, CY Kang, S Kim, LW Kwak, C Dong. (2007) "An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity." Blood 110. 2013-9 PMID: 17581919 DOI: 10.1182/blood-2006-12-061309 | Abstract and Keywords

GJ Renukaradhya, MA Khan, M Vieira, W Du, J Gervay-Hague, RR Brutkiewicz. (2008) "Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma." Blood 111. 5637-45 PMID: 18417738 DOI: 10.1182/blood-2007-05-092866 | Abstract and Keywords

D Assudani, HI Cho, N DeVito, N Bradley, E Celis. (2008) "In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells." Cancer Res 68. 9892-9 PMID: 19047170 DOI: 10.1158/0008-5472.CAN-08-3134 | Abstract and Keywords

TI Saito, HW Li, M Sykes. (2010) "Invariant NKT Cells Are Required for Antitumor Responses Induced by Host-Versus-Graft Responses" The Journal of Immunology 185. 2099-105 PMID: 20631307 DOI: 10.4049/jimmunol.0901985 | Abstract and Keywords

TI Saito, HW Li, M Sykes. (2010) "Invariant NKT Cells Are Required for Antitumor Responses Induced by Host-Versus-Graft Responses." J Immunol 185. 2099-105 PMID: 20631307 DOI: 10.4049/jimmunol.0901985 | Abstract and Keywords